Patents by Inventor Pushkar M. KULKARNI

Pushkar M. KULKARNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Allosteric modulators of CB1 cannabinoid receptors
    Patent number: 10246414
    Abstract: The present invention relates to novel heterocyclic derivatives which are allosteric modulators of cannabinoid receptor 1 (CB1) and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with endocannabinoid dysfunction and diseases in which the CB1 subtype of cannabinoid receptor is involved; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: April 2, 2019
    Assignee: Northeastern University
    Inventors: Ganeshsingh A. Thakur, Pushkar M. Kulkarni
  • Allosteric Modulators of CB1 Cannabinoid Receptors
    Publication number: 20170197918
    Abstract: The present invention relates to novel heterocyclic derivatives which are allosteric modulators of cannabinoid receptor 1 (CB1) and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with endocannabinoid dysfunction and diseases in which the CB1 subtype of cannabinoid receptor is involved; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
    Type: Application
    Filed: January 26, 2017
    Publication date: July 13, 2017
    Inventors: Ganeshsingh A. THAKUR, Pushkar M. KULKARNI
  • Allosteric modulators of CB1 cannabinoid receptors
    Patent number: 9556118
    Abstract: The present invention relates to novel heterocyclic derivatives which are allosteric modulators of cannabinoid receptor 1 (CB1) and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with endocannabinoid dysfunction and diseases in which the CB1 subtype of cannabinoid receptor is involved; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: January 31, 2017
    Assignee: Northeastern University
    Inventors: Ganeshsingh A. Thakur, Pushkar M. Kulkarni
  • ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS
    Publication number: 20150005346
    Abstract: The present invention relates to novel heterocyclic derivatives which are allosteric modulators of cannabinoid receptor 1 (CB1) and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with endocannabinoid dysfunction and diseases in which the CB1 subtype of cannabinoid receptor is involved; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 1, 2015
    Inventors: Ganeshsingh A. THAKUR, Pushkar M. KULKARNI